$213.76
N/A
Last update: Oct 20, 4:00 PM
$213.76
N/A
Jazz Pharmaceuticals PLC
JAZZNASDAQ
Jazz Pharmaceuticals (JAZZ) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Jazz Pharmaceuticals (JAZZ) last issued guidance on August 3, 2026 for fiscal year 2026. The company guided revenue in the range of $4.6B - $4.75B for the period.
Compared to prior guidance, Jazz Pharmaceuticals raised its revenue forecast from a prior range of $4.25B - $4.5B.
Jazz Pharmaceuticals has issued 20 guidance updates between November 9, 2022 and August 3, 2026. During this period, the company raised its outlook 9 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.94 | $4.49 | $6.16 | $5.43 |
| Actual | $5.71 | $6.34 | $6.64 | $8.13 |
| Surprise | -3.87% | +41.2% | +7.79% | +49.7% |
| Revenue | ||||
| Estimate | $1.11B | $977.6M | $1.17B | $1.11B |
| Actual | $1.21B | $1.61B | $1.20B | $1.13B |
| Surprise | +9.06% | +64.6% | +2.21% | +1.89% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $3.18 | $6.39 | $5.23 | $5.68 |
| Revenue | ||||
| Consensus | $1.21B | $1.24B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $5.71 | $5.94 | -3.87 % |
| Q1 | May 5, 2026 | $6.34 | $4.49 | 41.2 % |
| Q4 | Feb 24, 2026 | $6.64 | $6.16 | 7.79 % |
| Q3 | Nov 5, 2025 | $8.13 | $5.43 | 49.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $1.21B | $1.11B | 9.06 % |
| Q1 | May 5, 2026 | $1.61B | $977.61M | 64.6 % |
| Q4 | Feb 24, 2026 | $1.20B | $1.17B | 2.21 % |
| Q3 | Nov 5, 2025 | $1.13B | $1.11B | 1.89 % |
